Table 1.
Clinical Variable | Patients, No. (%) |
Patients | 35 (100%) |
Sex | |
Male | 18 (51%) |
Female | 17 (49%) |
Age, years | |
1–10 | 29 (83%) |
>10 | 6 (17%) |
Diagnosis | |
Wilms tumor | 14 (40%) |
Neuroblastoma | 10 (29%) |
Ewing Sarcoma | 4 (11%) |
Rhabdomyosarcoma | 4 (11%) |
Others | 3 (9%) |
Tumor Volume | |
<50 | 5 (14%) |
50–100 | 1 (3%) |
101–500 | 16 (46%) |
501–1000 | 8 (23%) |
>1000 | 4 (11%) |
Unknow | 1 (3%) |
Clinical Stage | |
I | 1 (3%) |
II | 9 (26%) |
III | 10 (29%) |
IV | 13 (37%) |
Unknow | 2 (6%) |
Metastasis at diagnosis | |
Yes | 17 (49%) |
No | 18 (51%) |
Metastasis during the treatment | |
Yes | 11 (31%) |
No | 19 (54%) |
Unknow | 5 (14%) |
cfDNA levels (ng/mL plasma) | |
<10 | 10 (29%) |
10–50 | 13 (37%) |
51–100 | 6 (17%) |
>100 | 6 (17%) |